Prognostic factors for survival in patients with non-resected non-small-cell lung cancer(Clinical staging IIIA N2, performance status 0, 1). A report from the symposium "treatment for clinical staging IIIA N2 non-small-cell lung cancer" at the 28th annual meeting of the Japan Lung Cancer society.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.